SCNI

#5158
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5914 USD
-0.10%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.5901
0.5914
Range Annuel
0.5500
1.0499
Changement quotidien
-0.10%
Changement Mensuel
-16.82%
Evolution sur 6 mois
-21.79%
Changement Annuel
-21.79%
Clôture Précédente
0.5920
Open
0.5901
Bid
Ask
Low
0.5901
High
0.5914
Volume
2
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 2.0511 M
  • Employee 31
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
791.22
Price to sales ratio
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Nouvelles